VEGFA and proliferative diabetic retinopathy: While treatments for proliferative diabetic retinopathy and vision-threatening DMO such as intravitreal anti-vascular endothelial growth factor (VEGF) injections exist, their invasiveness, cost and complications pose challenges [6].